What is Septate vagina?
Septate vagina (also known as vaginal septum or longitudinal vaginal septum) is a congenital malformation of the female reproductive tract in which a fibrous or fibromuscular wall (septum) divides the vaginal canal, either partially or completely, into two separate channels. This condition results from incomplete fusion or failed resorption of the Müllerian (paramesonephric) ducts during embryonic development. A septate vagina may occur as an isolated anomaly or in association with other Müllerian duct anomalies, such as uterus didelphys, bicornuate uterus, or septate uterus. It may also be associated with renal anomalies. Many individuals with a vaginal septum are asymptomatic and may not be diagnosed until puberty or adulthood. When symptoms occur, they can include dyspareunia (pain during intercourse), difficulty with tampon insertion or use, obstructed menstrual flow (which may cause hematocolpos — accumulation of menstrual blood in the vagina), dysmenorrhea (painful menstruation), and complications during vaginal delivery. In some cases, the septum may be discovered incidentally during a routine gynecological examination or during pregnancy. Treatment is typically surgical and involves excision or resection of the vaginal septum, a procedure that is generally straightforward and associated with good outcomes. Surgery is usually recommended when the septum causes symptoms such as pain, obstructed menstruation, difficulty with intercourse, or potential complications during childbirth. Prognosis after surgical correction is excellent, with most patients experiencing complete resolution of symptoms and normal reproductive function. Regular gynecological follow-up is recommended, particularly to assess for associated uterine or renal anomalies.
- Inheritance
- Multifactorial
- Caused by a mix of several genes and environmental factors
- Age of Onset
- Variable
- Can begin at different ages, from infancy through adulthood
Treatments
Source: openFDA + DailyMed · NDA / BLA labels with structured indications · refreshed weekly
No FDA-approved treatments are currently listed for Septate vagina.
View clinical trials →Clinical Trials
View all trials with filters →Source: ClinicalTrials.gov · synced daily · phases, status, and PI names normalized at ingest
No actively recruiting trials found for Septate vagina at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →Source: NPI Registry + PubMed · trial PI roles cross-referenced with ClinicalTrials.gov · ranked by match score (publications + PI activity + community signal)
No specialists are currently listed for Septate vagina.
Treatment Centers
8 centersSource: NORD Rare Disease Centers + NIH Undiagnosed Diseases Network (UDN) · centers verified active within last 12 months
Children's Hospital Colorado Rare Disease Program ↗
Children's Hospital Colorado
📍 Aurora, CO
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDBoston Children's Hospital Rare Disease Program ↗
Boston Children's Hospital
📍 Boston, MA
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
🏨 Children'sAnn & Robert H. Lurie Children's Hospital Genetics ↗
Lurie Children's Hospital
📍 Chicago, IL
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDCincinnati Children's Hospital Medical Center ↗
Cincinnati Children's
📍 Cincinnati, OH
👤 Boston Children's Hospital Rare Disease Program
🏨 Children'sNationwide Children's Hospital Rare Disease Center ↗
Nationwide Children's Hospital
📍 Columbus, OH
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
Travel Grants
No travel grants are currently matched to Septate vagina.
Community
No community posts yet. Be the first to share your experience with Septate vagina.
Start the conversation →Latest news about Septate vagina
Source: PubMed + NIH RePORTER + openFDA + clinical-journal RSS · last 30 days · disease-tagged at ingest by AI extraction with human QC
No recent news articles for Septate vagina.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Septate vagina
What is Septate vagina?
Septate vagina (also known as vaginal septum or longitudinal vaginal septum) is a congenital malformation of the female reproductive tract in which a fibrous or fibromuscular wall (septum) divides the vaginal canal, either partially or completely, into two separate channels. This condition results from incomplete fusion or failed resorption of the Müllerian (paramesonephric) ducts during embryonic development. A septate vagina may occur as an isolated anomaly or in association with other Müllerian duct anomalies, such as uterus didelphys, bicornuate uterus, or septate uterus. It may also be as
How is Septate vagina inherited?
Septate vagina follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Frequently asked questions about Septate vagina
Auto-generated from canonical disease facts (Orphanet, OMIM, ClinicalTrials.gov, openFDA, NPPES). Not a substitute for clinical guidance.
What is Septate vagina?
Septate vagina is a rare disease catalogued in international rare-disease ontologies (Orphanet ORPHA:180154). It is typically inherited as multifactorial. Age of onset is generally variable. For verified primary sources, see the UniteRare Septate vagina page.
How is Septate vagina inherited?
Septate vagina follows multifactorial inheritance. Genetic counseling is recommended for affected families to understand recurrence risk in offspring and the likelihood of unaffected siblings being carriers. Variants in the underlying gene(s) may be identified via clinical genetic testing.
Are there FDA-approved treatments for Septate vagina?
Approved treatments for Septate vagina are tracked from openFDA and DailyMed primary sources. Many rare diseases have no specific FDA-approved therapy; for those, supportive care and management of complications form the basis of clinical care. Orphan-drug-designation status is noted where applicable.
Are there clinical trials for Septate vagina?
Active clinical trials for Septate vagina are tracked daily from ClinicalTrials.gov. Trial availability changes frequently; check the UniteRare trial listings for the current count and recruitment status. Sponsors of rare-disease research often welcome inquiries even when a trial is not actively recruiting at a given moment.
How do I find a specialist for Septate vagina?
Verified Septate vagina specialists are identified through ClinicalTrials.gov principal-investigator records, peer-reviewed publication authorship (via PubMed), and the NPPES NPI registry. NORD-designated Centers of Excellence and NIH-affiliated rare-disease clinics are also tracked. UniteRare's specialist directory is updated continuously as new evidence becomes available.
See full Septate vagina page for complete clinical details, sources, and verified-specialist listings.
Cite this page
Select a citation format above to view and copy.